Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Go back to Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
(NASDAQ: AIFF) Delayed: 1.05 -0.01 (0.94%)
Previous Close $1.06    52 Week High $ 
Open $1.07    52 Week Low $ 
Day High $1.09    P/E N/A 
Day Low $1.03    EPS $ 
Volume 47,539